Delivery Order SPE2DB25D3021-SPE2DB25FQYLD
Award Date
5/12/25
Potential Completion Date
5/13/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,827.24, is a delivery order for the medical product "WEZLANA 90 MG/ML SYRINGEML" and has a completion date of June 4, 2025. The contract is a firm fixed-price arrangement, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,962.50, is for the procurement of 4567444668 ! WEZLANA 90 MG/ML SYRINGEML medical supplies. The contract has an ultimate completion date of March 4, 2025. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,568.57, is for the delivery of WEZLANA 90 MG/ML SYRINGEML, a pharmaceutical product. The contract has a completion date of June 12, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $37,218.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract provides for the delivery of "WEZLANA 90 MG/ML SYRINGEML", a pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568143127 WEZLANA 90 MG/ML SYRINGE. The contract has a firm fixed price of $31,769.95 and a period of performance through May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which provides comprehensive...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of WEZLANA 90 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $13,099.49. The contract is a Firm Fixed Price contract, with a period of performance through May 29, 2025. The contract is not set-aside and is open to full and open competition. Amerisourcebergen Drug Corp...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $14,405.68, for the provision of WEZLANA 90 MG/ML SYRINGEML pharmaceutical products. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,201.11 firm-fixed-price delivery order is for the supply of WEZLANA 90 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of May 27, 2025. Amerisourcebergen Drug Corp is also the holder of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567617054 ! WEZLANA 90 MG/ML SYRINGEML, a medical product, with a ceiling value of $5,568.57 and a period of performance ending on March 19, 2025. The contract is a Firm Fixed Price (FFP) delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $12,199.05, is a Delivery Order with a Firm Fixed Price pricing type. The award is for the supply of "WEZLANA 90 MG/ML SYRINGEML", a pharmaceutical product. The contract has an Ultimate Completion Date of April 4, 2025 and was awarded on April 3, 2025. The place of performance is...